Home Clinical Topics FDA approves new COPD treatment

FDA approves new COPD treatment

Author(s):

On July 23, the U.S. Food and Drug Administration (FDA) approved Tudorza Pressair (aclidinium bromide) for the long-term maintenance treatment of bronchospasm in patients with chronic obstructive pulmonary disease. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here